About Us
Why Engicoll?
Our purpose is to reshape the future of human health and wellness with responsible and advanced collagen.
Why collagen?
As people seek solutions for healthy aging, collagen has emerged as a key component in the medical, cosmetic and nutraceutical fields to enhance beauty, mobility, and overall quality of life.
Global collagen market is expected to reach $7b by 2030 with a 2023-2030 CAGR>5%. Market growth is fueled by the rising use of collagen peptides in the food supplement and functional food sector, more specifically in the beauty-from-within, mobility and sport nutrition segments targeting a broader and broader population, in the cosmetic sector, and in the healthcare sector.
Collagen is set to become the next hyaluronic acid!
While collagen has traditionally been extracted from animal tissues, first-generation recombinant collagen has already penetrated the healthcare market, is now entering the cosmetic market, and is targeting the food market, supported by strong demand for animal-free ingredients. However, it fails to provide higher efficacy compared to animal-extracted collagen, limiting its market penetration.
Our mission
ENGICOLL stems from the recognized expertise of David VANDROUX, PhD in collagen bioengineering, who filed 7 patent families in collagen, encompassing over 30 patents. David is the former CSO and CEO of NVH Medicinal, producing collagen for medical and cosmetic applications. ENGICOLL will rely on a long history of successful production of recombinant collagen through NVH Medicinal precision fermentation platform.
Our mission is to harness precision fermentation to deliver responsible advanced collagen to enhance human health and wellness.
Our vision
We aim to pioneer the development of the second generation of recombinant collagen, produced through precision fermentation, with a unique value proposition, improved efficacy, high purity and safety, animal-free nature, and high sustainability.
Our ambition is to become the B2B global leader in responsible advanced collagen for food applications, setting the standard for the next generation of collagen innovation and health & wellness solutions, meeting the market demand for animal-free, responsible, and highly effective ingredients.
2025
Founded
€800K
to be raised
Paris
Headquarters
2
CO-FOUNDERS
Our team
A Unified Team of Complementary Experts Driving Innovation
A team of experts, each bringing extensive experience in their field, steering the ship with visibility and confidence to guide partners toward groundbreaking advancements in collagen and human health & wellness.
Jacques MASSET
CEO
David VANDROUX
CSO